Cargando…
Progression of subclinical choroidal neovascularization in age-related macular degeneration
PURPOSE: To use optical coherence tomography angiography (OCTA) to study longitudinal subclinical choroidal neovascularization (CNV) changes and their correlation with progression to exudation in age-related macular degeneration (AMD). METHODS: This study included a total of 34 patients with unilate...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548359/ https://www.ncbi.nlm.nih.gov/pubmed/31163067 http://dx.doi.org/10.1371/journal.pone.0217805 |
_version_ | 1783423830706880512 |
---|---|
author | Heiferman, Michael J. Fawzi, Amani A. |
author_facet | Heiferman, Michael J. Fawzi, Amani A. |
author_sort | Heiferman, Michael J. |
collection | PubMed |
description | PURPOSE: To use optical coherence tomography angiography (OCTA) to study longitudinal subclinical choroidal neovascularization (CNV) changes and their correlation with progression to exudation in age-related macular degeneration (AMD). METHODS: This study included a total of 34 patients with unilateral neovascular AMD who were evaluated prospectively using OCTA to detect subclinical CNV in their fellow eye. Eyes with baseline subclinical CNV were followed with serial OCTA for a minimum of one year (15.2±3.27 months) to monitor the development of exudation. RESULTS: Of the 34 fellow eyes studied, five were found to have baseline subclinical CNV. One of the five cases of baseline subclinical CNV converted to exudative AMD during the follow up period. The average surface area of baseline subclinical CNV on OCTA was 0.131±0.096 mm(2) which progressed to 0.136±0.104 mm(2) at the final follow up (P = 0.539). Geographic atrophy grew at a rate of 0.82±1.20mm(2)/year in four eyes without subclinical CNV and 0.02mm(2)/year in one eye with subclinical CNV. CONCLUSION AND IMPORTANCE: The rate of conversion to exudative AMD in eyes with subclinical CNV of 20% in our study is similar to previous reports and suggests the importance of vigilance in these eyes. The lower growth rate of geographic atrophy may suggest a protective effect of subclinical CNV that deserves further study. |
format | Online Article Text |
id | pubmed-6548359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-65483592019-06-17 Progression of subclinical choroidal neovascularization in age-related macular degeneration Heiferman, Michael J. Fawzi, Amani A. PLoS One Research Article PURPOSE: To use optical coherence tomography angiography (OCTA) to study longitudinal subclinical choroidal neovascularization (CNV) changes and their correlation with progression to exudation in age-related macular degeneration (AMD). METHODS: This study included a total of 34 patients with unilateral neovascular AMD who were evaluated prospectively using OCTA to detect subclinical CNV in their fellow eye. Eyes with baseline subclinical CNV were followed with serial OCTA for a minimum of one year (15.2±3.27 months) to monitor the development of exudation. RESULTS: Of the 34 fellow eyes studied, five were found to have baseline subclinical CNV. One of the five cases of baseline subclinical CNV converted to exudative AMD during the follow up period. The average surface area of baseline subclinical CNV on OCTA was 0.131±0.096 mm(2) which progressed to 0.136±0.104 mm(2) at the final follow up (P = 0.539). Geographic atrophy grew at a rate of 0.82±1.20mm(2)/year in four eyes without subclinical CNV and 0.02mm(2)/year in one eye with subclinical CNV. CONCLUSION AND IMPORTANCE: The rate of conversion to exudative AMD in eyes with subclinical CNV of 20% in our study is similar to previous reports and suggests the importance of vigilance in these eyes. The lower growth rate of geographic atrophy may suggest a protective effect of subclinical CNV that deserves further study. Public Library of Science 2019-06-04 /pmc/articles/PMC6548359/ /pubmed/31163067 http://dx.doi.org/10.1371/journal.pone.0217805 Text en © 2019 Heiferman, Fawzi http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Heiferman, Michael J. Fawzi, Amani A. Progression of subclinical choroidal neovascularization in age-related macular degeneration |
title | Progression of subclinical choroidal neovascularization in age-related macular degeneration |
title_full | Progression of subclinical choroidal neovascularization in age-related macular degeneration |
title_fullStr | Progression of subclinical choroidal neovascularization in age-related macular degeneration |
title_full_unstemmed | Progression of subclinical choroidal neovascularization in age-related macular degeneration |
title_short | Progression of subclinical choroidal neovascularization in age-related macular degeneration |
title_sort | progression of subclinical choroidal neovascularization in age-related macular degeneration |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548359/ https://www.ncbi.nlm.nih.gov/pubmed/31163067 http://dx.doi.org/10.1371/journal.pone.0217805 |
work_keys_str_mv | AT heifermanmichaelj progressionofsubclinicalchoroidalneovascularizationinagerelatedmaculardegeneration AT fawziamania progressionofsubclinicalchoroidalneovascularizationinagerelatedmaculardegeneration |